同位素2011，Vol.24Issue(2)：118-123,6.
近距离治疗肿瘤的放射性粒子研究进展
Research Progress in Radioactive Seed for Brachytherapy
李忠勇 1高惠波 1金小海 1陈大明1
作者信息
- 1. 原子高科股份有限公司,北京,102413
- 折叠
摘要
Abstract
Brachytherapy is one of the most important technologies in the modern tumors treatment. 125Ⅰ seed and 103 Pd seed are applied widely and maturely, 103pd seed is considered to be more effective in treating aggressive and fast growing tumors, and 125Ⅰ seed has obvious advantages on slower growing tumors. Seed strand and hybrid seed are two important direction of the research concerning the brachytherapy seed, especially in the 103 pd-125Ⅰ composite seed can combine the characteristics of the two kinds of nuclides. Thus, the 103pd-125 Ⅰ hybrid seed has important clinical significance and broad application prospect. The history of the technology is reviewed; the seeds of variety used in brachytherapy are introduced, as well as their application; the advantages and disadvantages of brachytherapy are analyzed;and the research progress of the seed is summed up.关键词
恶性肿瘤/近距离治疗/放射性粒子/103Pd-125I复合粒子Key words
malignant tumor/ brachytherapy/ radioactive seed/ 103 pd-125 Ⅰ hybrid seed分类
医药卫生引用本文复制引用
李忠勇,高惠波,金小海,陈大明..近距离治疗肿瘤的放射性粒子研究进展[J].同位素,2011,24(2):118-123,6.
